Ws Management Lllp Uni Qure N.V. Transaction History

Ws Management Lllp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$52.76 - $82.19 $3.18 Million - $4.96 Million	-60,304 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$27.39 - $68.41 $221,749 - $553,847	-8,096 Reduced 11.84%	60,304 $3.6 Million
Q4 2018 Feb 12, 2019	SELL	$22.8 - $33.93 $1.03 Million - $1.53 Million	-45,100 Reduced 39.74%	68,400 $1.97 Million
Q2 2018 Aug 13, 2018	BUY	$21.96 - $39.94 $2.49 Million - $4.53 Million	113,500 New	113,500 $4.29 Million

149

34.1M

1.07M

603K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $177M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Ws Management Lllp, based on Form 13F filings with the SEC.

Stay updated on Ws Management Lllp with notifications on news.